As a joint degree student, I benefit from immersive case studies at HBS where my classmates and I are challenged to analyze the business and ethical considerations of each managerial decision. On the other hand, at the Harvard Stem Cell and Regenerative Biology department, we interrogate scientific papers and consider the business case for the commercialization of cutting-edge science. Both programs surgically align with my goal of becoming one of many players impacting the broader health care and life sciences industry. [...]